Literature DB >> 10346996

Potential role of environmental factors in the etiology and pathogenesis of atopy: a working model.

P G Holt1.   

Abstract

Sensitization to inhalant allergens commonly commences in utero, and most children are born with weak T helper-2 (Th2)-polarized T-cell immunity to these agents. During early life, these responses are normally deviated toward the Th1 cytokine profile. However, in atopics this immune deviation process fails, leading instead to consolidation of allergen-specific Th2 immunity and its eventual active expression in the airways. Both the induction and expression of Th2 immunity can be modulated by environmental agents that affect the cytokine milieu in the airway mucosa and/or the draining lymph nodes. Because of the known effects of the mold cell wall component (1-->3)-ss-d-glucan on monocyte cytokine secretion, exposure to molds during childhood may be a significant etiologic factor in allergic respiratory disease in general.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10346996      PMCID: PMC1566234          DOI: 10.1289/ehp.99107s3485

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  18 in total

1.  Developing patterns of T cell memory to environmental allergens in the first two years of life.

Authors:  S L Prescott; C Macaubes; A Yabuhara; T J Venaille; B J Holt; W Habre; R Loh; P D Sly; P G Holt
Journal:  Int Arch Allergy Immunol       Date:  1997 May-Jul       Impact factor: 2.749

Review 2.  Induction of TH1 and TH2 responses: a key role for the 'natural' immune response?

Authors:  S Romagnani
Journal:  Immunol Today       Date:  1992-10

3.  Regulation of IgE production in pre-sensitized animals: in vivo elimination of alveolar macrophages preferentially increases IgE responses to inhaled allergen.

Authors:  T Thepen; C McMenamin; B Girn; G Kraal; P G Holt
Journal:  Clin Exp Allergy       Date:  1992-12       Impact factor: 5.018

Review 4.  Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon?

Authors:  T G Wegmann; H Lin; L Guilbert; T R Mosmann
Journal:  Immunol Today       Date:  1993-07

Review 5.  Immunological/physiological relationships in asthma: potential regulation by lung macrophages.

Authors:  L W Poulter; G Janossy; C Power; S Sreenan; C Burke
Journal:  Immunol Today       Date:  1994-06

6.  Update on the immunomodulating activities of glucans.

Authors:  N R Di Luzio
Journal:  Springer Semin Immunopathol       Date:  1985

7.  The relationship between upper respiratory infections and hospital admissions for asthma: a time-trend analysis.

Authors:  S L Johnston; P K Pattemore; G Sanderson; S Smith; M J Campbell; L K Josephs; A Cunningham; B S Robinson; S H Myint; M E Ward; D A Tyrrell; S T Holgate
Journal:  Am J Respir Crit Care Med       Date:  1996-09       Impact factor: 21.405

8.  Expression of interleukin 1 family mRNAs by a highly branched (1-->3)-beta-D-glucan, OL-2.

Authors:  J Nemoto; N Ohno; K Saito; Y Adachi; T Yadomae
Journal:  Biol Pharm Bull       Date:  1993-10       Impact factor: 2.233

9.  Dendritic cells are recruited into the airway epithelium during the inflammatory response to a broad spectrum of stimuli.

Authors:  A S McWilliam; S Napoli; A M Marsh; F L Pemper; D J Nelson; C L Pimm; P A Stumbles; T N Wells; P G Holt
Journal:  J Exp Med       Date:  1996-12-01       Impact factor: 14.307

10.  (1-->3)-beta-D-glucan and endotoxin modulate immune response to inhaled allergen.

Authors:  R Rylander; P G Holt
Journal:  Mediators Inflamm       Date:  1998       Impact factor: 4.711

View more
  2 in total

Review 1.  Vaccination strategies to reduce the risk of leukaemia and melanoma.

Authors:  John M Grange; John L Stanford; Cynthia A Stanford; Klaus F Kölmel
Journal:  J R Soc Med       Date:  2003-08       Impact factor: 5.344

Review 2.  Environmental tobacco smoke, indoor allergens, and childhood asthma.

Authors:  D R Gold
Journal:  Environ Health Perspect       Date:  2000-08       Impact factor: 9.031

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.